US Presidential Elections: Are Prescription Drug Pricing Reforms Losing Political Luster?

Neither Kamala Harris nor Donald Trump mentioned drug pricing reforms in their presidential convention speeches.

Harris Will Tout The Administration's Drug Pricing Reforms But May Not Produce New Ones.

US Vice President Kamala Harris did not mention plans for lowering prescription drug pricing in her speech accepting the Democratic party nomination as candidate for president 22 August, which might signal a cooling in the political rhetoric around further reforms.

Key Takeaways

  • Democratic presidential nominee Kamala Harris did not refer to drug pricing reform in her speech at the party convention last night, nor did Republican nominee Donald Trump at his convention last month.

Granted the speech was light on any policy specifics in general. For example, Harris pledged only to “lower the cost...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access